Guangzhou LBP Medicine Science & Technology Co (SHSE:688393) Net Change in Cash : ¥-21.8 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Guangzhou LBP Medicine Science & Technology Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Guangzhou LBP Medicine Science & Technology Co's Net Change in Cash for the three months ended in Mar. 2024 was ¥-19.3 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-21.8 Mil.

Guangzhou LBP Medicine Science & Technology Co Net Change in Cash Historical Data

The historical data trend for Guangzhou LBP Medicine Science & Technology Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangzhou LBP Medicine Science & Technology Co Net Change in Cash Chart

Guangzhou LBP Medicine Science & Technology Co Annual Data

Trend

Dec12

Dec13

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

10.74

547.35

-416.58

-126.46

-22.39

Guangzhou LBP Medicine Science & Technology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial															-20.09	-11.46	2.94	6.07	-19.31

Guangzhou LBP Medicine Science & Technology Co Net Change in Cash Calculation

Guangzhou LBP Medicine Science & Technology Co's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	17.121	+	-32.698	+	-6.894	+	0.08
	=	-22.4

Guangzhou LBP Medicine Science & Technology Co's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -24.476 + 25.54 + -20.375 + 0

= -19.3

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-21.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangzhou LBP Medicine Science & Technology Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Guangzhou LBP Medicine Science & Technology Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangzhou LBP Medicine Science & Technology Co (SHSE:688393) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Guangzhou LBP Medicine Science & Technology Co Ltd (SHSE:688393) » Definitions » Net Change in Cash

Comparable Companies

SHSE:688026 SZSE:300753 SZSE:300030 SHSE:688329 SHSE:688013 SZSE:301097 SHSE:688067 SHSE:603880 SZSE:300061 SZSE:300453 ISRG XPAR:EL BDX XSWX:ALC TSE:7741 WST OCSE:COLO B RMD TSE:4543 XSWX:STMN

Traded in Other Exchanges

N/A

Address

Building 7, No. 11, Nanxiang 3rd Road, Guangzhou High-tech Industrial Development Zone, Guangdong Province, Guangzhou, CHN, 510663

Website

http://www.gzlbp.com

Guangzhou LBP Medicine Science & Technology Co Ltd is engaged in production and sales of in vitro diagnostic reagents and instruments. The company's products include Fluorescence in situ hybridization (FISH) series; Immunohistochemistry (IHC) series; Liquid - based cytology (LBP) series; PCR series; and medical laboratory.

Guangzhou LBP Medicine Science & Technology Co (SHSE:688393) Headlines

No Headlines